Subgroup results from KARDIA-2: impact of demographic and baseline disease characteristics on zilebesiran response in patients with hypertension uncontrolled by a standard oral antihypertensive
Event: ESC Congress 2024
Topic: Pharmacotherapy
Session: Pharmacological management of hypertension
